中国医药导刊
中國醫藥導刊
중국의약도간
CHINESE JOURNAL OF MEDICAL GUIDE
2014年
7期
1185-1186
,共2页
血清降钙素原变化率%指导%重症细菌性肺炎%疗效评估
血清降鈣素原變化率%指導%重癥細菌性肺炎%療效評估
혈청강개소원변화솔%지도%중증세균성폐염%료효평고
Rate of change of serum procalcitonin%Guidance%Severe bacterial pneumonia%Efifcacy assessment
目的：对血清降钙素原变化率在指导重症细菌性肺炎疗效进行探讨。方法：随机抽取25例重症细菌性肺炎患者，为观察组，另选取同时期我院治疗的轻症肺炎患者25例，为对照组，对两组患者在24h之内的血常规、体温、血清PCT、CRP水平等进行对比，分析两组患者的呼吸机使用例数、住院时间、抗生素使用情况以及死亡率。结果：观察组患者的CRP、血清PCT明显高于对照组（P＜0.05）。而两组患者在中性粒细胞百分比、WBC计数以及体温差异等方面差异不明显（P＞0.05）。PCT水平越高，重症肺炎患者越需要使用呼吸机进行辅助呼吸，患者的死亡率，抗生素使用与患者的住院时间相应增加。结论：在重症细菌性肺炎患者治疗中应用血清降钙素原，能够提高疾病的诊断有效率，具有一定的指导价值和评估作用，提高患者预后。
目的：對血清降鈣素原變化率在指導重癥細菌性肺炎療效進行探討。方法：隨機抽取25例重癥細菌性肺炎患者，為觀察組，另選取同時期我院治療的輕癥肺炎患者25例，為對照組，對兩組患者在24h之內的血常規、體溫、血清PCT、CRP水平等進行對比，分析兩組患者的呼吸機使用例數、住院時間、抗生素使用情況以及死亡率。結果：觀察組患者的CRP、血清PCT明顯高于對照組（P＜0.05）。而兩組患者在中性粒細胞百分比、WBC計數以及體溫差異等方麵差異不明顯（P＞0.05）。PCT水平越高，重癥肺炎患者越需要使用呼吸機進行輔助呼吸，患者的死亡率，抗生素使用與患者的住院時間相應增加。結論：在重癥細菌性肺炎患者治療中應用血清降鈣素原，能夠提高疾病的診斷有效率，具有一定的指導價值和評估作用，提高患者預後。
목적：대혈청강개소원변화솔재지도중증세균성폐염료효진행탐토。방법：수궤추취25례중증세균성폐염환자，위관찰조，령선취동시기아원치료적경증폐염환자25례，위대조조，대량조환자재24h지내적혈상규、체온、혈청PCT、CRP수평등진행대비，분석량조환자적호흡궤사용례수、주원시간、항생소사용정황이급사망솔。결과：관찰조환자적CRP、혈청PCT명현고우대조조（P＜0.05）。이량조환자재중성립세포백분비、WBC계수이급체온차이등방면차이불명현（P＞0.05）。PCT수평월고，중증폐염환자월수요사용호흡궤진행보조호흡，환자적사망솔，항생소사용여환자적주원시간상응증가。결론：재중증세균성폐염환자치료중응용혈청강개소원，능구제고질병적진단유효솔，구유일정적지도개치화평고작용，제고환자예후。
Objective: To investigate the rate of change of serum procalcitonin in guiding the efficacy of severe bacterial pneumonia explore. Methods: Ran domed 25 cases of severe bacterial pneumonia, As the observation group, Another selected 25 cases with mild pneumonia while in our hospital, As the control group, Two groups of patients within 24h of blood, body temperature, serum PCT, CRP level of contrast to the two groups of patients with ventilator number of cases, hospitalization, use of antibiotics, and mortality were analyzed. Results: The patients of CRP, serum PCT was significantly higher, there is a big difference, with statistical significance(P<0.05). The two groups of patients in terms of the percentage of neutrophils, WBC count, and no significant difference between the temperature differences do not have statistical significance(P>0.05). The higher PCT levels in patients with severe pneumonia need to use more ventilator-assisted breathing, increased mortality, length of stay and antibiotic use in patients will also be extended. Conclusion: Serum procalcitonin in patients with severe bacterial pneumonia treatment applications, can improve the efficiency of diagnosis of diseases, reflect the true condition of the patient, the diagnosis of severe bacterial pneumonia has a guiding value and assess the role of improve patient prognosis.
